Table 4: Univariate survival analysis of PFS and OS in 70 patients with endometrial carcinoma.

VariableNumberEstimated 5-year
PFS (%)
-valueEstimated 5-year
OS (%)
-value

Age (years)0.1980.881
 ≤602268.277.3
 >604882.480.9
FIGO stage<0.0010.016
 I + II3994.789.7
 III + IV3156.166.7
Grade0.0070.016
 G13093.393.3
 G2 + G34065.369.2
Lymph node metastasis0.0110.010
 Negative4985.087.8
 Positive2160.060.0
Depth of myometrial invasion0.0050.051
 ≤1/23192.990.3
 >1/23965.671.1
LVS involvement<0.001<0.001
 Negative4492.995.5
 Positive2650.652.0
Peritoneal cytology<0.001<0.001
 Negative5392.292.5
 Positive1727.337.5
Wnt7a0.0050.042
 Negative4466.572.1
 Positive2696.092.3

FIGO: International Federation of Gynecology and Obstertics; LVS: lymph vascular space; PFS: progression-free survival; OS: overall survival and *log-rank test.